Integrated Cell Line Development - Abzena

Cell Line Development Resources for Biologics

Read and download our resources to learn how we can streamline your cell line development workflow and accelerate cell line delivery.

From producing cutting-edge vaccines to developing Antibody-Drug Conjugates (ADCs) to treat cancer, the use of stable cell lines to develop and produce biotherapeutics is moving the biopharmaceutical industry forward. Cell line development (CLD) is challenging. It is the linchpin in the development and manufacturing of biologics and bioconjugates.

Despite streamlined processes and advances in technology solutions, workflows can be slow to produce successes and carry risk. Developing a biologic, such as a targeted monoclonal antibody (mAb), and delivering it to the market where there is a patient in need requires years of research and discovery, development, clinical trials and scale up for commercialization.

Abzena’s scientific experts in cell line development are ready to help answer your questions and collaborate with you. Here you can find and learn from our expert CLD resources. If you have any questions or would like to speak with an expert please contact us.

Discover and learn more from our resources

Looking to move your cell line development forward and take it to the next level?

Please tell us about yourself and your program. Our experts will be in touch soon.